Doug Skinner

Left of the Board

Shaping the AI bets before anything gets built: strategy, governance, and adoption in clinical research.

By Doug Skinner · Director, AI Solution Strategy, ParexelWhy the name? →

Featured essay

2 min read

What real-time clinical trials actually demand

The FDA's Real-Time Clinical Trials pilot gets talked about as a regulatory shift. It's really an infrastructure one.

Read essay

Latest

All writing →

Career

Leaving Engineering

After a career spent building products and the teams that build them, I'm shifting my focus to the left of the board: making the right AI bets.

2 min read

Recent notes

All notes →

Counting agents

IQVIA's latest earnings call had a number that's going to get repeated a lot: 415 AI agents deployed, up from 192 in Q1. They also credited those agents with lifting win rates by two to three points. That's real traction, and it's tied to bookings, not just a demo count. But…

Explore by topic

AI Governance1AI Strategy1Career1Clinical Trials1Engineering Leadership1